Congenital Hypertrophy of Retinal Pigment Epithelium
Understand Congenital Hypertrophy of Retinal Pigment Epithelium (CHRPE), also known as Retinal Pigment Hypertrophy. Learn about CHRPE diagnosis, clinical documentation, and medical coding for healthcare professionals. Find information on CHRPE symptoms, associated conditions, and relevant medical terminology for accurate clinical records and billing. This resource provides essential guidance for documenting and coding CHRPE in healthcare settings.
Flat, dark pigmented spots on the retina, typically benign and congenital.
Bear tracks or grouped pigmented lesions on fundus exam, often asymptomatic.
Ophthalmology or optometry clinics during routine eye exams.
ICD-10 Code Families
Complete code families applicable to Q14.1
When to use each related code
| Description | When to use |
|---|---|
| Flat, dark spots on the retina. | CHRPE, often incidental finding during eye exam. Usually benign. |
| Elevated, dark pigmented lesions on retina. | Suspect choroidal nevus. Monitor for growth. Consider referral if changes noted. |
| Malignant tumor of the retinal pigment epithelium. | Rare, unilateral dark lesion with rapid growth and symptoms. Urgent referral. |
Best-practice checklist
- ✓Document CHRPE lesion size, shape, and color.
- ✓Note CHRPE location (e.g., peripheral, juxtapapillary).
- ✓Record number of CHRPE lesions present.
- ✓Differentiate between typical and atypical CHRPE features.
- ✓Rule out other retinal pigment epithelial lesions.
Common pitfalls to avoid
Missing or incorrect laterality (right, left, bilateral) for CHRPE can impact reimbursement and data accuracy. Proper ICD-10-CM coding with modifiers is crucial for compliance.
Documentation must differentiate between isolated CHRPE and CHRPE associated with Gardner syndrome (familial adenomatous polyposis) for accurate coding (ICD-10 Q12.0 vs. H10.31).
Distinguishing solitary CHRPE from multiple lesions affects coding and potential association with systemic conditions, requiring clear documentation for accurate medical coding and billing.
Best-practice tips
- 01Document CHRPE laterality (unilateral/bilateral) for accurate ICD-10 coding (H35.02).
- 02Distinguish CHRPE from choroidal melanoma via clinical findings, imaging, and CDI queries.
- 03Rule out Gardner syndrome with comprehensive history, exam, and appropriate referrals if multiple/large CHRPE.
- 04Genetic counseling for familial adenomatous polyposis (FAP) if CHRPE linked to Gardner syndrome.
- 05Regular ophthalmic exams to monitor CHRPE for any changes and ensure proper HCC coding.
Step-by-step checklist
- 1
Confirm unilateral or multifocal pigmented lesions flat, well-circumscribed
- 2
Bear tracks or grouped CHRPE suggests familial adenomatous polyposis
- 3
Evaluate for lacunae within lesions indicative of CHRPE
- 4
Rule out other retinal pigment epithelium alterations like choroidal nevus
- 5
Document CHRPE features, size, and location using ICD-10 H35.52
Ready-to-paste narrative
Patient presents for ophthalmological evaluation with a suspected Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE). Review of systems includes questions regarding visual acuity, field defects, flashes, floaters, or any family history of CHRPE or Gardner syndrome. Ophthalmoscopic examination reveals a flat, well-demarcated, pigmented lesion consistent with CHRPE. The lesion exhibits characteristic features such as lacunae within the hyperpigmentation and a depigmented halo. Differential diagnosis includes choroidal nevus, melanoma of the choroid, and other retinal pigment epithelial lesions. Given the benign nature of isolated CHRPE findings, management consists of routine ophthalmologic monitoring for any changes in size, shape, or pigmentation. Patient education regarding the natural history of CHRPE and the importance of regular eye exams is provided. ICD-10 code H35.52 (other retinal disorders) is appropriate for billing and coding this condition. Further investigation and genetic counseling may be considered if multiple or bilateral CHRPE lesions are present, raising suspicion for familial adenomatous polyposis (FAP) or Gardner syndrome. Medical decision making is straightforward given the classic clinical presentation.
Common questions and answers
How can I differentiate Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) from choroidal melanoma during a funduscopic exam?+
Differentiating CHRPE from choroidal melanoma is crucial for appropriate management. CHRPE typically presents as a flat, well-circumscribed lesion with a lacunae, or depigmented halo. It often has sharp margins and may demonstrate a characteristic 'bearing tracks' appearance. In contrast, choroidal melanoma tends to be elevated, dome-shaped, and may exhibit orange pigment, subretinal fluid, or overlying drusen. Furthermore, melanoma often grows over time, while CHRPE is generally stable. Ultrasound biomicroscopy (UBM) or optical coherence tomography (OCT) can be used to confirm the diagnosis if there is diagnostic uncertainty. Explore how imaging modalities like UBM and OCT can enhance the diagnostic accuracy in differentiating CHRPE from other suspicious pigmented lesions. Consider implementing a routine follow-up schedule for patients with pigmented lesions to monitor for any changes.
What are the recommended management and follow-up protocols for patients diagnosed with Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE), especially when multiple lesions are present?+
Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) is typically benign and requires no intervention for solitary lesions. However, multiple or grouped CHRPE lesions, especially if large and/or demonstrating atypical features like thickening or irregular margins, may raise suspicion for Gardner syndrome, a variant of familial adenomatous polyposis (FAP). In such cases, a thorough systemic evaluation, including a family history and potentially genetic testing for APC gene mutations, is warranted. Consider implementing a comprehensive risk assessment for FAP and genetic counseling for patients with multiple or atypical CHRPE lesions. Learn more about the association between CHRPE and Gardner syndrome to better manage patients with this finding.
Are there any specific genetic associations or syndromes linked to multiple or grouped Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) lesions? What are the implications for patient care?+
The presence of multiple or grouped CHRPE lesions, particularly those exceeding four in number, is strongly associated with Gardner syndrome, an autosomal dominant inherited disorder caused by mutations in the APC gene. Gardner syndrome is characterized by the triad of intestinal polyposis (which has a high risk of malignant transformation to colon cancer), multiple osteomas, and soft tissue tumors. Given this significant association, patients with multiple CHRPE lesions should undergo careful screening for colonic polyps and other manifestations of Gardner syndrome. Explore how genetic testing and family history assessment can inform patient management and contribute to early detection and prevention of associated complications in patients with multiple CHRPE lesions.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.